Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing
Top Cited Papers
Open Access
- 19 August 2004
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (8) , 760-768
- https://doi.org/10.1056/nejmoa040085
Abstract
Testing of blood donors for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) RNA by means of nucleic acid amplification was introduced in the United States as an investigational screening test in mid-1999 to identify donations made during the window period before seroconversion.Keywords
This publication has 29 references indexed in Scilit:
- First report of human immunodeficiency virus transmission via an RNA‐screened blood donationVox Sanguinis, 2004
- Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United StatesVox Sanguinis, 2004
- Dynamics of HIV viremia and antibody seroconversion in plasma donorsAIDS, 2003
- Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNAJournal of Clinical Microbiology, 2002
- Emerging Infectious Agents: Do They Pose a Risk to the Safety of Transfused Blood and Blood Products?Clinical Infectious Diseases, 2002
- Seroprevalence of known and putative hepatitis markers inUnited States blood donors with ALT levels at least 120 IU per LTransfusion, 2001
- NAT and blood safety: what is the paradigm?Transfusion, 2000
- Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseasesTransfusion, 2000
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- Hepatitis C virus infections in transplant patients: Serological and virological investigationsJournal of Medical Virology, 1994